Insmed (INSM) Net Cash Flow (2016 - 2026)
Insmed's Net Cash Flow history spans 17 years, with the latest figure at $72.3 million for Q1 2026.
- Quarterly Net Cash Flow rose 147.35% to $72.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $179.5 million through Mar 2026, up 192.97% year-over-year, with the annual reading at -$45.5 million for FY2025, 161.54% down from the prior year.
- Net Cash Flow came in at $72.3 million for Q1 2026, down from $175.7 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $880.1 million in Q2 2025 to a low of -$948.6 million in Q3 2025.
- The 5-year median for Net Cash Flow is -$5.8 million (2023), against an average of -$7.8 million.
- Year-over-year, Net Cash Flow tumbled 3783.94% in 2023 and then soared 1752.77% in 2024.
- Insmed's Net Cash Flow stood at $660.5 million in 2022, then tumbled by 100.87% to -$5.8 million in 2023, then skyrocketed by 1752.77% to $95.1 million in 2024, then surged by 84.76% to $175.7 million in 2025, then plummeted by 58.85% to $72.3 million in 2026.
- Per Business Quant, the three most recent readings for INSM's Net Cash Flow are $72.3 million (Q1 2026), $175.7 million (Q4 2025), and -$948.6 million (Q3 2025).